Ligand Pharmaceuticals director Jason Aryeh reports sale of $676,158.1448 in common shares
LGND•Director Jason Aryeh sold 2,161 Ligand Pharmaceuticals common shares, according to a Form 4 filed Nov. 3, 2026. He held 108,758 shares directly and 8,000 indirectly after the sales.
1. Share sales
Aryeh sold 1,461 shares on Oct. 30 at prices ranging from $317.74 to $320.49, and another 700 shares on Nov. 2 at $320.4261 per share. After the transactions, he held 108,758 shares directly and 8,000 indirectly.
